Zomedica Corp. Q3 FY2025 Earnings Call

Zomedica Corp. (ZOMDF)

Earnings Call FY2025 Q3 Call date: 2025-11-04 Concluded

Quarter scorecard

Revenue

$8.10M

+15.7% YoY

Diluted EPS

$-0.01

Gross margin

67.2%

-5.1 pp YoY

Net income

-$6.12M

Therapeutics $6.67M

+2.8%

Diagnostics $762,000

+50.3%

Development Services $662,000